Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGO

Por Molina, Jean-Michel, Clotet, Bonaventura, van Lunzen, Jan, Lazzarin, Adriano, Cavassini, Matthias, Henry, Keith, Kulagin, Valeriv, Givens, Naomi, Brennan, Clare, de Oliveira, Carlos Fernando
Publicado no J Int AIDS Soc (2014)